Private Label Bakuchiol Vitamin C Eye Cream Manufacturer

The minimum order quantity for private label bakuchiol vitamin C eye cream depends on whether you choose a stock formula or a custom-developed formula. Stock formulas — pre-tested base formulations already containing bakuchiol and a stabilized vitamin C derivative — typically start at 200 to 500 units per SKU. This low entry point exists because the manufacturer has already absorbed the R&D and stability-testing cost. You are essentially paying for filling, packaging, and labeling. Custom formulation raises the MOQ meaningfully. If you want a unique actives ratio, a specific texture (gel-cream vs. balm), or additional ingredients like peptides or hyaluronic acid, most manufacturers require 500 to 2,500 units to justify the development cost and to run a production batch large enough for in-process quality checks to be statistically valid. Several factors can move the MOQ up or down. Packaging choice is one of the biggest levers — an airless pump tube sourced from a manufacturer's existing inventory has a lower component MOQ than a bespoke glass jar with a custom-anodized lid. Fill size also matters: a 15 ml tube and a 30 ml tube are often treated as separate SKUs, so ordering two sizes doubles your production run but splits the per-unit cost of shared development. Geography is another variable. US-based and EU-based manufacturers often have higher per-unit costs but lower MOQs (200–500 units) and shorter lead times with simpler logistics. Asian manufacturers, particularly those in South Korea and China with strong K-beauty and C-beauty heritage in eye-area actives, frequently offer lower per-unit costs but push MOQs to 1,000–3,000 units and add 4–6 weeks of shipping. If your launch volume is genuinely below 200 units, a white-label reseller — rather than a direct manufacturer relationship — may be your only realistic option, though your margin and differentiation will be limited. Once you cross 500 units per SKU, you have real negotiating leverage with most contract cosmetic manufacturers. A common mistake first-timers make is quoting a low MOQ verbally and then discovering the component MOQ (e.g., 1,000 units of a custom-printed airless pump) is actually the binding constraint. Always confirm MOQ at the finished-goods level, not just the formula level. AJ Cosmo Labs lets you filter manufacturers by their actual finished-goods MOQ inside the iOS app, so you only spend time talking to partners who can genuinely work at your volume.

The cost to private label a bakuchiol vitamin C eye cream sits in a wide range — roughly $4 to $18 per finished unit — depending on formula route, packaging tier, fill volume, and order quantity. Understanding what sits inside each cost band is more useful than a single average figure. At $4–$7 per unit you are typically working with a stock formula in a manufacturer's existing airless pump or jar, at 200–500 unit quantities. The bakuchiol will be at 0.5% and the vitamin C derivative (usually ascorbyl glucoside, which is more stable than L-ascorbic acid in an eye cream context) at 2–3%. Label printing and simple packaging are included. This tier is common among Taiwanese and some US contract fillers. At $7–$12 per unit the manufacturer adds semi-custom elements: your brand-specific label, a choice of two or three jar or tube options from their approved packaging library, and potentially a light formula tweak such as adding niacinamide or caffeine. MOQ at this tier is typically 500–1,000 units. At $12–$18 per unit you are in fully custom territory — bespoke formula, custom-sourced packaging (glass with a gold pump, for example), higher actives concentrations (bakuchiol at 1%, vitamin C derivative at 4–5%), and potentially additional actives like tripeptide-1 or retinyl palmitate. Development fees of $1,500–$5,000 are common at this tier, charged once and amortized across your first production run. Beyond the per-unit cost, budget for one-time setup items: formula development fee ($0 for stock, $1,500–$5,000 for custom), stability testing ($500–$2,500 depending on scope), label artwork and regulatory review ($300–$1,500), and freight. Import duties on finished cosmetics entering the US from Asia typically run 6–7%. Bakuchiol is a premium active — expect the raw ingredient alone to add $0.30–$0.80 per unit compared to a basic eye cream without it. Vitamin C derivatives vary: ascorbyl glucoside and ethyl ascorbic acid are more expensive than ascorbic acid but far more stable in cream emulsions, which is non-negotiable for eye-area products that need a 24–36 month shelf life. The most common budgeting mistake is forgetting packaging component costs when manufacturing overseas. If your jar is sourced separately from a packaging supplier and shipped to the filler, you pay a toll-filling fee ($0.50–$2.00 per unit) on top of the formula cost. Posting your brief on AJ Cosmo Labs with your target cost-per-unit is an effective way to quickly identify which manufacturers can compete within your budget without running a lengthy RFQ process.

Total lead time from your first supplier conversation to finished goods on your doorstep runs 8 to 26 weeks depending on the formula route you choose and how quickly you can approve samples and artwork. For a stock formula private label eye cream — where the manufacturer already has a validated bakuchiol vitamin C base — the timeline compresses significantly. Week 1 to 2: you submit your brief and the manufacturer ships a sample of their existing formula. Week 2 to 4: you review the sample, approve or request a minor adjustment. Week 4 to 6: label artwork is finalized, regulatory copy reviewed. Week 6 to 10: production run, in-process QC, finished-goods release and shipping. That puts stock-formula projects at roughly 8–12 weeks if you move decisively through approvals. Custom formulation adds time at every stage. A cosmetic chemist needs 3–6 weeks to develop a first prototype from your brief. Each subsequent iteration — texture adjustment, fragrance change, actives tweak — adds 2–3 weeks. Two rounds of iteration is typical, which means formula development alone can consume 8–12 weeks before you even start stability testing. Stability and microbial challenge testing can be run in parallel with formula iteration and label development, but only if the formula is unlikely to change significantly. Accelerated stability (ICH: 40 °C / 75% RH) requires a minimum of 12 weeks to generate data that predicts a 24-month shelf life. Manufacturers with an existing stability dataset on their base formula shorten this dramatically for stock-formula clients. Regulatory and artwork approvals are an under-estimated bottleneck. INCI list verification, claims review, and (for EU) the Cosmetic Product Safety Report can each take 2–4 weeks if the responsible person or in-house regulatory team is backlogged. Production itself — once formula, packaging, and artwork are all approved — typically takes 2–5 weeks depending on batch size and the manufacturer's queue. Post-holiday periods (January, post-Chinese New Year) are the worst time to be entering a production queue. If you are targeting a product launch tied to a retail deadline, work backward from that date with a 20% schedule buffer and communicate it explicitly in your initial brief. AJ Cosmo Labs lets you set a target launch date in your project brief so manufacturers can immediately flag if the timeline is achievable, saving weeks of back-and-forth.

Bakuchiol and vitamin C can absolutely be co-formulated in a stable eye cream, but it requires deliberate choices about which vitamin C derivative you use, what pH you target, and what antioxidant support system you build around both actives. L-ascorbic acid (pure vitamin C) is the most biologically active form but also the most unstable. It oxidizes rapidly above pH 3.5, turning the product yellow-orange and losing efficacy. Eye creams are typically formulated at pH 5.5–7 for skin-barrier and comfort reasons, which makes pure L-ascorbic acid a poor choice for this application. Experienced cosmetic chemists almost universally substitute a stabilized derivative: ascorbyl glucoside (stable up to pH 7, non-irritating), ethyl ascorbic acid (good stability at pH 5–6, strong skin-brightening data), or sodium ascorbyl phosphate (water-soluble, stable, mild). Bakuchiol itself is relatively stable. It is a meroterpene phenol that does not degrade as rapidly as retinol, and unlike retinol it does not require strict light-protection packaging (though UV-resistant packaging is still a sensible precaution for any active-ingredient eye cream). Bakuchiol's oil solubility means it typically sits in the lipid phase of the emulsion, while vitamin C derivatives are generally water-soluble and sit in the aqueous phase — this physical separation actually helps co-stability. The formulator's job is to choose an emulsion architecture (o/w is most common for eye creams, with a light, non-occlusive finish) that keeps the aqueous phase at the right pH and includes a chelating agent like EDTA or phytic acid to sequester metal ions that would otherwise catalyze ascorbic acid oxidation. An antioxidant synergist such as tocopherol (vitamin E) in the oil phase further stabilizes bakuchiol and provides secondary antioxidant backup. When requesting samples, ask the manufacturer specifically for accelerated stability data showing color (spectrophotometry or visual grading), pH drift, and HPLC quantification of the vitamin C derivative at T0, T4 weeks, T8 weeks, and T12 weeks at 40 °C / 75% RH. A well-formulated product should show less than 10% active degradation and no significant color shift at T12 weeks. The most common mistake indie founders make is accepting a sample that looks and feels great at T0 without requesting stability data. Six months after launch, customer complaints about product discoloration or reduced efficacy trace back almost always to a stability shortcut. Manufacturers listed on AJ Cosmo Labs are vetted for their active-ingredient formulation capability, so you can ask directly in your brief whether the supplier has ICH stability data on their bakuchiol vitamin C base before engaging.

The minimum certification baseline for any credible private label eye cream manufacturer is ISO 22716:2007 (Cosmetics Good Manufacturing Practices). This is the international GMP standard audited by a third party and recognized by regulators in the US, EU, and most major export markets. A manufacturer who cannot produce their ISO 22716 certificate or equivalent GMP audit report should not handle your product. Beyond ISO 22716, the certifications you need depend on your brand's claims, target markets, and customer values. For the US market, FDA registration of the manufacturing facility is required for OTC drug products but not for cosmetics. However, voluntary registration under the FDA Voluntary Cosmetic Registration Program (VCRP) — and increasingly mandatory registration under the Modernization of Cosmetics Regulation Act (MoCRA, effective 2024) — signals a more compliance-forward manufacturer. MoCRA now requires domestic and foreign facilities that manufacture cosmetics sold in the US to register with the FDA, so confirm your supplier is compliant. For the EU market, the Responsible Person (RP) must hold a Cosmetic Product Safety Report (CPSR) completed by a qualified safety assessor. If your manufacturer is outside the EU, you will need to appoint an EU-based RP yourself or through a regulatory service. The manufacturer's ability to provide a full product information file (PIF) — including formula, raw material safety data sheets, method of manufacture, stability data, and safety assessment — is non-negotiable. If your brand is positioned as natural or organic, look for COSMOS-standard certification (for EU/UK) or USDA Organic certification if you are making that claim in the US. The bakuchiol raw material should come from a COSMOS-approved supplier, and the vitamin C derivative must also appear on the COSMOS approved ingredients list — ascorbyl glucoside and sodium ascorbyl phosphate are both approved; some others are not. Cruelty-free certification (Leaping Bunny or PETA) is a consumer-facing claim, not a regulatory requirement, but it is increasingly a retail gate for natural beauty channels and DTC brands. Confirm the manufacturer does not test on animals and can provide a cruelty-free declaration. Vegan certification (The Vegan Society or equivalent) requires confirming no animal-derived ingredients — relevant if your formula contains beeswax, carmine, or certain collagen sources. For California specifically, any product containing ingredients on the Prop 65 list above threshold levels requires a point-of-sale warning. A competent manufacturer should be able to provide a Prop 65 screening assessment. AJ Cosmo Labs admin-reviews all manufacturers on the platform before they are approved to receive briefs, which removes the burden of cold-verifying credentials yourself.

Finding a vetted, low-MOQ cosmetic manufacturer for a bakuchiol vitamin C eye cream requires more than a Google search — the most capable manufacturers rarely need to advertise aggressively, and directories often list outdated or unverified entries. For US-based manufacturing, the primary sourcing channels are trade associations (PCPC, ICMAD), trade shows (Cosmoprof North America, Make Your Beauty), and direct referrals from cosmetic chemists or packaging suppliers. US manufacturers typically offer MOQs of 200–500 units for stock formulas, cGMP and MoCRA-compliant facilities, faster shipping, and easier communication — but at higher per-unit cost ($7–$18 range) than Asian alternatives. States with high concentrations of cosmetic contract manufacturers include California (Los Angeles area), New Jersey, New York, and Texas. South Korea is the dominant source for innovative eye-area formulations, especially those featuring cutting-edge actives like bakuchiol, peptides, and fermented ingredients. K-beauty ODM/OEM manufacturers (Kolmar Korea, Cosmax, Intercos Korea, and hundreds of smaller houses) have deep experience with lightweight eye-cream emulsions and often have existing stable bakuchiol bases. MOQs from Korean manufacturers typically start at 1,000–3,000 units for custom work, though some smaller Korean ODMs offer 500-unit entry points for semi-custom. Lead times add 6–10 weeks for ocean freight to the US or EU. When vetting any manufacturer, request: their ISO 22716 certificate with the issuing body and expiry date; a filled sample of the specific base formula you are interested in; a list of three recent client brands (NDAs permitting, they can confirm the relationship without disclosing formulas); and their standard quality control specification sheet (appearance, pH, viscosity, microbial limits) for the product type. Red flags to walk away from: manufacturers who cannot provide stability data, who ask for unusually large upfront payments (more than 30–50% before production is common; 100% upfront is a warning sign), who have no third-party GMP audit on file, or who cannot provide an INCI-accurate ingredient list. The fastest way to skip the cold-sourcing process entirely is to post a detailed project brief on AJ Cosmo Labs. The iOS app connects you with pre-vetted US, Korean, and European manufacturers who have already been screened for GMP compliance and active-ingredient capability, and you can filter by MOQ and geography before you even send a message.

Cosmetic claims in the US and EU must be truthful, not misleading, and must not cross into drug-claim territory by asserting that your product alters the structure or function of the skin beyond superficial appearance. In the United States, the FDA regulates cosmetics under the Federal Food, Drug, and Cosmetic Act. A claim like 'visibly reduces the appearance of fine lines' is a cosmetic claim — it describes a visible, aesthetic effect. A claim like 'clinically reverses periorbital wrinkles' implies a physiological change and edges toward a drug claim, requiring you to comply with OTC drug monograph rules or submit a New Drug Application. For eye creams specifically, avoid any language suggesting the product penetrates below the epidermis, rebuilds collagen structurally, or treats a condition (e.g., 'treats dark circles caused by poor circulation'). For bakuchiol, claim language supported by published research includes: 'bakuchiol, a plant-based alternative to retinol,' 'helps visibly firm the look of skin,' and 'smooths the appearance of fine lines without irritation.' For vitamin C (ascorbyl glucoside or ethyl ascorbic acid), well-supported language includes: 'brightens the look of dark circles,' 'helps even skin tone,' and 'antioxidant-rich formula.' Both are reasonable and defensible for a properly formulated product. In the European Union, the EU Cosmetics Regulation (EC 1223/2009) defines a cosmetic as a product intended to clean, perfume, change appearance, or keep in good condition — not to treat or prevent disease. The same drug-claim line exists. The EU additionally requires that all claims be backed by evidence held in the Product Information File and that claims are not exaggerated or misleading under the Common Criteria for claims (Regulation 655/2013). 'Clinically tested' and 'dermatologist tested' are permissible in the EU if the testing actually occurred and is documented — they are not regulated terms but are subject to the general truthfulness requirement. For eye-area products specifically, both the US and EU prohibit claims suggesting the product has an effect on the eyeball itself or treats ophthalmological conditions. 'For use around the eye area' is fine; 'improves eye health' is not. If you want to use a clinical efficacy claim ('shown in a clinical study to reduce the appearance of crow's feet by X%'), you must conduct and document an actual consumer perception or instrumental study with the finished product. Borrowing claims from the raw material supplier's ingredient study is not compliant unless your finished product formula and concentration match the study conditions. AJ Cosmo Labs connects you with manufacturers who have regulatory affairs support and can review your label copy before production, which is one of the most cost-effective ways to catch problematic claims before they reach retail.